Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

KPV: Evidence Summary

Name: KPV Evidence Summary — Clinical Trial Data
Published: 2026-03-12

Evidence summary for KPV across studied indications. Each indication is graded using our evidence tier system based on the quality and quantity of available clinical data.

Back to KPV overview

Indication	Evidence Tier	Trial Count	Summary
Gut inflammation (IBD)	Tier C	2	Alpha-MSH fragment reduces TNF-α and NF-κB in colitis models; limited human data
Antimicrobial activity	Tier D	0	In vitro activity against Candida and Staphylococcus; no clinical trials